This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sashida, G.
Right arrow Articles by Nimer, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sashida, G.
Right arrow Articles by Nimer, S. D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2009, p. 3687-3699, Vol. 29, No. 13
0270-7306/09/$08.00+0     doi:10.1128/MCB.01551-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

ELF4/MEF Activates MDM2 Expression and Blocks Oncogene-Induced p16 Activation To Promote Transformation{triangledown} ,{dagger}

Goro Sashida,1 Yan Liu,1 Shannon Elf,1 Yasuhiko Miyata,1 Kazuma Ohyashiki,3 Miki Izumi,4 Silvia Menendez,1 and Stephen D. Nimer1,2*

Molecular Pharmacology and Chemistry Program of the Sloan-Kettering Institute,1 Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York,2 Department of Hematology,3 Department of Diagnostic Pathology, Tokyo Medical University, Tokyo, Japan4

Received 3 October 2008/ Returned for modification 11 November 2008/ Accepted 13 April 2009

Several ETS transcription factors, including ELF4/MEF, can function as oncogenes in murine cancer models and are overexpressed in human cancer. We found that Elf4/Mef activates Mdm2 expression; thus, lack of or knockdown of Elf4/Mef reduces Mdm2 levels in mouse embryonic fibroblasts (mef's), leading to enhanced p53 protein accumulation and p53-dependent senescence. Even though p53 is absent in Elf4–/– p53–/– mef's, neither oncogenic H-RasV12 nor c-myc can induce transformation of these cells. This appears to relate to the INK4a/ARF locus; both p19ARF and p16 are increased in Elf4–/– p53–/– mef's, and expression of Bmi-1 or knockdown of p16 in this context restores H-RasV12-induced transformation. Thus, ELF4/MEF promotes tumorigenesis by inhibiting both the p53 and p16/Rb pathways.

* Corresponding author. Mailing address: Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Phone: (212) 639-7871. Fax: (212) 794-5849. E-mail: nimers{at}mskcc.org

{triangledown} Published ahead of print on 20 April 2009.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

Molecular and Cellular Biology, July 2009, p. 3687-3699, Vol. 29, No. 13
0270-7306/09/$08.00+0     doi:10.1128/MCB.01551-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»